Vanguard Fiduciary Trust
DXCM icon

Vanguard Fiduciary Trust’s DexCom DXCM Stock Holding History

Vanguard Fiduciary Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149M Sell
2,217,179
-5,380
-0.2% -$358K 0.03% 411
2026
Q1 		$140M Buy
+2,222,559
New +$155M 0.04% 406

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Fiduciary Trust's DXCM Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its DexCom (DXCM) stake by 0.24% in Q2 2026, selling an estimated $358K and leaving 2,217,179 shares worth $149M. The position accounts for 0.03% of the portfolio, ranked #411.

Vanguard Fiduciary Trust first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 959 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Vanguard Fiduciary Trust held 2,217,179 shares of DexCom worth $149M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 5,380 DexCom shares in Q2 2026, an estimated $358K.
  • DexCom made up 0.03% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #411 holding.
  • Vanguard Fiduciary Trust first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.